Why is Exagen, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -0.58% of over the last 5 years
2
Flat results in Jun 25
- CASH AND EQV(HY) Lowest at USD 41.23 MM
- INTEREST(Q) Highest at USD 1.12 MM
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 90.12%, its profits have risen by 19.9%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Exagen, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Exagen, Inc.
59.36%
3.16
90.84%
S&P 500
13.22%
0.61
20.17%
Quality key factors
Factor
Value
Sales Growth (5y)
8.47%
EBIT Growth (5y)
-0.58%
EBIT to Interest (avg)
-9.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.70
Sales to Capital Employed (avg)
1.35
Tax Ratio
0.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
42.51%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
24.75
EV to EBIT
-12.10
EV to EBITDA
-13.77
EV to Capital Employed
9.80
EV to Sales
2.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-81.03%
ROE (Latest)
-242.18%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
7What is working for the Company
NET PROFIT(HY)
Higher at USD -7.46 MM
RAW MATERIAL COST(Y)
Fallen by -0.52% (YoY
NET SALES(Q)
Highest at USD 17.2 MM
OPERATING PROFIT MARGIN(Q)
Highest at -12.58 %
-8What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 41.23 MM
INTEREST(Q)
Highest at USD 1.12 MM
Here's what is working for Exagen, Inc.
Net Profit
Higher at USD -7.46 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
Highest at USD 17.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 17.2 MM has Grown at 21.3%
over average net sales of the previous four periods of USD 14.18 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -12.58 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -0.52% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Exagen, Inc.
Interest
At USD 1.12 MM has Grown at 106.24%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 1.12 MM
in the last five periods and Increased by 106.24% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Cash and Eqv
Lowest at USD 41.23 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






